S100A8/A9-mediated control of the G2/M cell cycle checkpoint is, therefore, a likely suppressive mechanism in human squamous cell carcinomas and may suggest new therapeutic approaches. This evidence concerns the gene IGKV1D-22 and squamous cell carcinoma.